Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T
Third Department of Internal Medicine, Yamanashi Medical University, Tamaho, Yamanashi 409-38, Japan.
J Clin Invest. 1998 Apr 1;101(7):1296-300. doi: 10.1172/JCI1259.
Iodide is concentrated to a much lesser extent by papillary thyroid carcinoma as compared with the normal gland. The Na+/I- symporter (NIS) is primarily responsible for the uptake of iodide into thyroid cells. Our objective was to compare NIS mRNA and protein expression in papillary carcinomas with those in specimens with normal thyroid. Northern blot analysis revealed a 2.8-fold increase in the level of NIS mRNA in specimens with papillary carcinoma versus specimens with normal thyroid. Immunoblot analysis using anti-human NIS antibody that was produced with a glutathione S-transferase fusion protein containing NIS protein (amino acids 466-522) showed the NIS protein at 77 kD. The NIS protein level was elevated in 7 of 17 cases of papillary carcinoma but was not elevated in the normal thyroid. Immunohistochemical staining revealed abundant NIS in 8 of 12 carcinomas, whereas NIS protein was barely detected in specimens with normal thyroid. Although considerable patient-to-patient variation was observed, our results indicate that NIS mRNA is elevated, and its protein tends to be more abundant, in a subset of papillary thyroid carcinomas than in normal thyroid tissue.
与正常甲状腺组织相比,甲状腺乳头状癌对碘化物的摄取程度要低得多。钠/碘同向转运体(NIS)主要负责将碘化物摄取到甲状腺细胞中。我们的目的是比较甲状腺乳头状癌与正常甲状腺标本中NIS mRNA和蛋白的表达情况。Northern印迹分析显示,与正常甲状腺标本相比,甲状腺乳头状癌标本中NIS mRNA水平增加了2.8倍。使用含有NIS蛋白(氨基酸466 - 522)的谷胱甘肽S - 转移酶融合蛋白制备的抗人NIS抗体进行免疫印迹分析,结果显示NIS蛋白分子量为77 kD。17例甲状腺乳头状癌中有7例NIS蛋白水平升高,而正常甲状腺组织中未升高。免疫组织化学染色显示,12例癌中有8例NIS丰富,而正常甲状腺标本中几乎检测不到NIS蛋白。尽管观察到患者之间存在相当大的差异,但我们的结果表明,在一部分甲状腺乳头状癌中,NIS mRNA水平升高,其蛋白往往比正常甲状腺组织中更丰富。